Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Solomon

Showing results (1251-1260 of 1,388) with videos related to

Pageof 139
Sort By:
Clinical Pharmacokinetics|December 11, 2023
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung CancerJoseph Chen, Alessandra Bearz, Dong-Wan Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2024
Choroid plexus volume differentiates MS from its mimicsElle Levit, Zheng Ren, Virgilio Gonzenbach, et al.
Annals of the American Thoracic Society|April 12, 2016
Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung DiseaseAmar Mannina, Jonathan H Chung, Jeffrey J Swigris, et al.
Science Translational Medicine|January 27, 2012
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung CancersRyohei Katayama, Alice T Shaw, Tahsin M Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2022
Selpercatinib in Patients With <i>RET</i> Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II TrialAlexander Drilon, Vivek Subbiah, Oliver Gautschi, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 12, 2025
A Novel Convolutional Neural Network for Automated Multiple Sclerosis Brain Lesion SegmentationEmma Dereskewicz, Francesco La Rosa, Jonadab Dos Santos Silva, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysisMarliese Alexander, Malinda Itchins, Jonathan Felthun, et al.
Investigational New Drugs|February 7, 2024
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trialAndrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Frontiers in Neurology|June 26, 2023
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosisRebecca I Spain, Andrea Hildebrand, Carin S Waslo, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 31, 2023
Pediatric Acute Respiratory Distress Syndrome in South African PICUs: A Multisite Point-Prevalence StudyBrenda M Morrow, Eleonora Lozano Ray, Mignon McCulloch, et al.
Pageof 139

Showing results (1251-1260 of 1,388) with videos related to

Sort By:
Pageof 139
Clinical Pharmacokinetics|December 11, 2023
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung CancerJoseph Chen, Alessandra Bearz, Dong-Wan Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2024
Choroid plexus volume differentiates MS from its mimicsElle Levit, Zheng Ren, Virgilio Gonzenbach, et al.
Annals of the American Thoracic Society|April 12, 2016
Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung DiseaseAmar Mannina, Jonathan H Chung, Jeffrey J Swigris, et al.
Science Translational Medicine|January 27, 2012
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung CancersRyohei Katayama, Alice T Shaw, Tahsin M Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2022
Selpercatinib in Patients With <i>RET</i> Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II TrialAlexander Drilon, Vivek Subbiah, Oliver Gautschi, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 12, 2025
A Novel Convolutional Neural Network for Automated Multiple Sclerosis Brain Lesion SegmentationEmma Dereskewicz, Francesco La Rosa, Jonadab Dos Santos Silva, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysisMarliese Alexander, Malinda Itchins, Jonathan Felthun, et al.
Investigational New Drugs|February 7, 2024
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trialAndrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Frontiers in Neurology|June 26, 2023
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosisRebecca I Spain, Andrea Hildebrand, Carin S Waslo, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 31, 2023
Pediatric Acute Respiratory Distress Syndrome in South African PICUs: A Multisite Point-Prevalence StudyBrenda M Morrow, Eleonora Lozano Ray, Mignon McCulloch, et al.
Pageof 139